It’s quite simple. Sell out cheap to a big, powerful,
It’s quite simple. Sell out cheap to a big, powerful, lobbyist infested BP and you get approval.
And I’m not joking here. It’s completely obvious the FDA has no intention of approving this drug, or anything from CYDY. Too much $$, too much influence.
It’s great when the little guy scores a big win. TSLA did, and despite what many think of its CEO he delivered. NP is no Elon Musk and the latter only had to deal with the DOT.
So here we sit wondering what to do next. SP is about $1 a share below my average. As I said in a previous post I do think the drug had value, and I also think BP knows this as well. I ABSOLUTELY believe AF is in the employ of at least one BP entity. The ultimate goal of a short is to drive the targeted company into insolvency. Those that are paying AF would like this as well. Pick up LL for pennies, just like CYDY did. My only hope now is that more than one BP with very deep pockets will see the value and a bidding war will result. 3 digits, AYFKM? We’d be lucky to see 2, but I’d take it now to get out and put my $$ elsewhere. So call me what you will, I’m holding on to hopefully recoup some $$. I’ll refer to myself as a “shaken long”.
BTW maybe, just maybe we hit bottom this morning, as long we don’t get any more communications from NP.
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Lockton's Strategic Appointment of a New COO Lockton, a leader in the insurance brokerage industry, has made a significant move by appointing Lisa Hawker as the Chief Operating Officer for its People Solutions division. This strategic decision is aimed at fostering continued growth and enhancing Lockton’s operational capabilities within this essential business segment....
Continue Reading
KBR, Inc. Faces Class Action Lawsuit Over Contract Issues KBR, Inc. (NYSE: KBR) is currently embroiled in a class-action lawsuit that has captured the attention of investors. The legal suit alleges that the company provided misleading information regarding a significant military contract before its unexpected cancellation. This suit was prompted by a sharp decline in...
Continue Reading
Understanding Middlefield Canadian Income PCC's Net Asset Value Middlefield Canadian Income PCC is recognized for its robust investment strategies and commitment to delivering value to its shareholders. Details on Net Asset Value As of the latest data, the estimated unaudited Net Asset Value (NAV) per share was reported at 142.13 pence. This figure includes accrued...
Continue Reading
Transforming the Future of AI Innovation The recent announcement of a substantial grant to Plug and Play marks a pivotal moment in advancing artificial intelligence. The Knight Foundation has awarded a generous $2 million to propel the establishment of a collaborative AI ecosystem aimed at fostering innovation and stimulating economic growth. Launch of the AI Center of...
Continue Reading
DAZN Group to Acquire Foxtel from News Corp In an exciting development in the media landscape, News Corp (NASDAQ: NWSA) has announced its intention to sell its Australian television unit, Foxtel Group, to the renowned British sports streaming platform, DAZN Group. This transaction involves an impressive enterprise value of A$3.4 billion, which translates to approximately...
Continue Reading